Martín-Hernández, David https://orcid.org/0000-0003-0195-2604
Caso, Javier R. https://orcid.org/0000-0001-8622-749X
Díaz-García, César https://orcid.org/0009-0006-2019-8570
Regidor, Pedro-Antonio https://orcid.org/0000-0002-9551-2847
Rizo, José Miguel
Román, Marta
Gutiérrez, Rocío
Leza, Juan Carlos https://orcid.org/0000-0002-9901-0094
Funding for this research was provided by:
Universidad Complutense de Madrid
Article History
Received: 4 July 2025
Accepted: 19 February 2026
First Online: 9 March 2026
Declarations
:
: José Miguel Rizo, Marta Román, and Rocío Gutiérrez report financial support was provided by Chemo OTC Spain. Pedro-Antonio Regidor reports financial support was provided by Exeltis Healthcare. David Martín Hernández, Javier R. Caso, Pedro-Antonio Regidor, José Miguel Rizo, Rocío Gutiérrez, and Juan Carlos Leza have patent #EP24382507.2 pending to CHEMO RESEARCH, S.L.